Barclays analyst Gena Wang lowered the firm’s price target on Kodiak Sciences to $2 from $5 and keeps an Underweight rating on the shares after the company announced the discontinuation of KSI-301.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on KOD: